{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for piperacetazine in Related Substance Name (approximate match)
Showing 1 - 1 of 1 results
Status:
US Previously Marketed
Source:
QUIDE by DOW PHARM
(1969)
Source URL:
First approved in 1969
Source:
QUIDE by DOW PHARM
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Piperacetazine (Quide) is an antipsychotic prodrug, most notably used for schizophrenia. The study indicates that Quide is a useful addition to the armamentarium of the physician faced with the difficult problem of treating the chronic hospitalized patient with a schizophrenic illness. Side effects of the drug were generally mild, and there was no evidence that it would produce blood dyscrasias or liver impairment.